Further limitations are the relative small number of patients and the short mean follow-up of only 28 month.
The techniques, along with relative summary of advantages and limitations, are listed in Tables 6a and 6b.
Other potential limitations are the relative short follow-up period and the evaluation of only fatal events related to metabolic syndrome.
Limitations are: First, the relative small number of participating practices (63) may reduce the generalizability of our results to the Swiss primary care.
Since our interest lies in the relationship between the two GP based actions of diagnosing and prescribing (Does the GP base prescribing of medication on his decision whether or not to diagnose a child with asthma?), these last two limitations are of only relative importance to our study.
My message is simple: your limitations are not my limitations.
Other limitations are more subjective.
Airbourne's limitations are obvious.
The only limitations were the relative small sample size and the low number of SNPs, for which we cannot really reach a similar genome-wide significance threshold in humans (will discuss below).
